Ursolic acid and rosiglitazone combination prevent low-grade inflammation and hepatic insulin resistance by modulating cytokine expression in mice fed a high-fat diet
International Journal of Clinical Medical Research · 2023
DOI: 10.61466/ijcmr1030013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Medical Research, 2023. Verfasst von Arjunan Sundaresan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The objective of this research endeavor was to assess the effects of rosiglitazone (RSG) and ursolic acid (UA) on hepatic insulin signaling indicators and inflammatory marker concentrations in C57/BL/6J mice that were provided with a high-fat diet (HFD).
Methods
C57BL/6J mice were fed a HFD for 16 weeks and orally administered UA (5 mg/kg BW), RSG (4 mg/kg BW), and UA (5 mg/kg BW) + RSG (4 mg/kg BW) for the last 6 weeks.
Results
The HFD groups showed a significant increase in leptin, TNF-α, and IL-6, whereas adiponection level significantly decreased. The expression of insulin signaling markers in the liver also significantly increased in HFD mice.
Conclusions
Combination treatment improves above said parameters than individual parameters. These data suggest that combination treatment (UA with RSG) has potential benefits for the treatment of HFD-induced insulin resistance, and its effects may be associated with improvements in the inhibition of the expression of inflammatory markers in plasma and liver.
Zitieren
APA
Sundaresan, A., Radhiga, T., & Pugalendi, K. V. (2023). Ursolic acid and rosiglitazone combination prevent low-grade inflammation and hepatic insulin resistance by modulating cytokine expression in mice fed a high-fat diet. International Journal of Clinical Medical Research. https://doi.org/10.61466/ijcmr1030013
Vancouver
Sundaresan A, Radhiga T, Pugalendi KV. Ursolic acid and rosiglitazone combination prevent low-grade inflammation and hepatic insulin resistance by modulating cytokine expression in mice fed a high-fat diet. International Journal of Clinical Medical Research. 2023. doi:10.61466/ijcmr1030013
BibTeX
@article{Sundaresan2023,
author = {Sundaresan, Arjunan and Radhiga, Thangaiyan and Pugalendi, Kodukkur Viswanathan},
title = {Ursolic acid and rosiglitazone combination prevent low-grade inflammation and hepatic insulin resistance by modulating cytokine expression in mice fed a high-fat diet},
journal = {International Journal of Clinical Medical Research},
year = {2023},
doi = {10.61466/ijcmr1030013}
}
EUVIMED